May 27, 2026
Early Detection of Melanoma Recurrence through Gene-Based Blood Test
Researchers at NYU Langone Health and NYU Grossman School of Medicine have developed a gene-based blood test that may enable the early detection of melanoma recurrence. This innovative approach has the potential to improve patient outcomes by allowing for timely intervention.